GAIL (India) Ltd Q1 FY27 Results Analysis: PAT Jumps 127.6%, EBITDA Margin Expands 630 bps
GAIL (India) Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 38,981.63 Cr (+12.00% YoY) and PAT growth of +127.60% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | July 31, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 38,981.63 Cr (+12.00% YoY) |
| PAT (Q1) | Rs. 4,292.33 Cr (+127.60% YoY) |
| EBITDA margin | 16.40% (+630 bps YoY) |
| EPS (Q1) | Rs. 6.53 (+127.50% YoY) |
| Market cap | Rs. 119,360.47 Cr |
| CMP | Rs. 181.44 |
Quarter Snapshot
GAIL reported strong Q1 FY27 results with PAT up 127.6% YoY and EBITDA margin expanding 630 bps, driven by operating leverage and a sharp recovery in Natural Gas Marketing. Positive catalysts include regulatory tariff hikes and APM gas allocation, but headwinds from LNG supply disruptions and a rising debt-equity ratio temper the outlook.
Key Investment Insights
Key Positives
- PAT grew 127.6% YoY to Rs.4,292 crore.
- EBITDA margin expanded 630 bps YoY to 16.4%.
- Natural Gas Marketing segment EBIT surged 224.9% YoY to Rs.3,481 crore, recovering from a loss in Q4.
- LPG & Liquid Hydrocarbons EBIT rose 276.8% YoY to Rs.773 crore.
- Revenue grew 12.0% YoY to Rs.38,982 crore.
- Operating expenses grew only 3.8% YoY, demonstrating operating leverage.
Risk Factors
- LNG supply disruptions from West Asia impacted seven cargoes; mitigation through spot procurement.
- Finance costs increased 47.9% YoY due to higher borrowings.
- Petrochemicals segment remained loss-making at Rs.123 crore loss (though narrowed from Rs.249 Cr).
- Debt-equity ratio rose to 0.32x from 0.24x YoY.
- Contingent liability of Rs.3,799 crore on naphtha classification dispute.
- No independent directors on board since March 2026.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.